BioCryst Pharmaceuticals
BCRX
#5070
Rank
โ‚น145.79 B
Marketcap
โ‚น691.81
Share price
2.26%
Change (1 day)
4.92%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: โ‚น145.79 Billion

As of December 2025 BioCryst Pharmaceuticals has a market cap of โ‚น145.79 Billion. This makes BioCryst Pharmaceuticals the world's 5070th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น145.79 B6.42%
2024โ‚น137.00 B34.14%
2023โ‚น102.13 B-42.33%
2022โ‚น177.09 B-4.53%
2021โ‚น185.49 B92.82%
2020โ‚น96.20 B153.78%
2019โ‚น37.90 B-38.96%
2018โ‚น62.10 B101.31%
2017โ‚น30.85 B-2.76%
2016โ‚น31.72 B-36.93%
2015โ‚น50.30 B-9.28%
2014โ‚น55.45 B99.87%
2013โ‚น27.74 B601.19%
2012โ‚น3.95 B-33.02%
2011โ‚น5.90 B-43.28%
2010โ‚น10.41 B-20.86%
2009โ‚น13.16 B422.41%
2008โ‚น2.51 B-72.64%
2007โ‚น9.20 B-38.51%
2006โ‚น14.97 B-31.05%
2005โ‚น21.71 B298.75%
2004โ‚น5.44 B-2.28%
2003โ‚น5.57 B585.68%
2002โ‚น0.81 B-75.84%
2001โ‚น3.36 B-37.96%
2000โ‚น5.42 B-75.51%
1999โ‚น22.14 B397.23%
1998โ‚น4.45 B17.14%
1997โ‚น3.80 B-52.86%
1996โ‚น8.06 B

End of Day market cap according to different sources

On Dec 25th, 2025 the market cap of BioCryst Pharmaceuticals was reported to be:

โ‚น145.79 Billion
by Nasdaq info icon info icon
โ‚น145.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Repligen
RGEN
โ‚น837.81 B 474.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น210.13 B 44.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น2.30 B-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น101.32 B-30.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น14.009 T 9,509.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น160.17 B 9.87%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น8.902 T 6,006.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
โ‚น60.53 B-58.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น3.36 B-97.69%๐Ÿ‡บ๐Ÿ‡ธ USA